New book by Larry Connors - Click here to read more
Provident Bankshares Corp. (NASDAQ: PBKS | Quote | Chart | News | PowerRating) operates as the holding company for Provident Bank, which provides commercial banking services to individuals and businesses. The company's deposit accounts include noninterest-bearing, interest-bearing demand, money market, savings, direct time certificates of deposits, and brokered certificates of deposits. Its consumer loan products include installment loans secured by real estate, boats, automobiles, home equity lines, and unsecured personal lines of credit; commercial real estate loan products comprise commercial and residential construction loans, as well as intermediate-term commercial mortgages; commercial business lending products consist of term loans, equipment leases, and revolving lines of credit for the purpose of current asset financing, equipment purchases, owner occupied real estate financing, and business expansion; and non-performing assets and delinquent loans include non-accrual loans, renegotiated loans, and real estate and other assets that have been acquired through foreclosure or repossession. The company also provides securities brokerage, investment management, and related insurance services; and telephone and Internet banking services. As of December 31, 2007, it served various customers in the areas of Baltimore, Washington, and Richmond through a network of 143 banking offices and 242 ATMs in Maryland and Virginia, as well as in southern York County, Pennsylvania. The company was founded in 1886 and is based in Baltimore, Maryland. With 33.15 million shares outstanding and 11.02 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of PBKS. According to quarterly data provided by the SEC, there were still 480,157 shares of PBKS that were failing-to-deliver as of December 22, 2004.
Rubicon Technology Inc. (NASDAQ: RBCN | Quote | Chart | News | PowerRating) engages in developing, manufacturing, and selling monocrystalline sapphire and other innovative crystalline products for light-emitting diodes (LEDs), radio frequency integrated circuits (RFICs), blue laser diodes, optoelectronics, and other optical applications. It fabricates its products from the boules and sells them in various categories, including core, as-cut, as-ground, and polished. The company offers two inch, three inch, four inch, and six inch diameter wafers in C, R, A, and M planar orientations. It also manufactures sapphire substrates and optical windows, such as two to four inch sapphire wafers for use in LEDs and blue laser diodes for solid state lighting and electronic applications. In addition, Rubicon Technology offers six inch sapphire wafers that are used for Silicon-on-Sapphire RFICs, as well as products for military, aerospace, sensor, and other applications. Further, the company provides optically-polished windows and ground window blanks of sapphire and various fluoride compounds, such as calcium, barium, and magnesium fluoride. It provides its products to wafer polishing companies and semiconductor device manufacturers in Asia, North America, and Europe. The company is based in Franklin Park, Illinois. With 21.17 million shares outstanding and 2.45 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of RBCN. According to quarterly data provided by the SEC, there were still 166,517 shares of RBCN that were failing-to-deliver as of May 9, 2008.
Duska Therapeutics Inc. (OTCBB: DSKA | Quote | Chart | News | PowerRating) through its subsidiary, Duska Scientific Co., operates as a biopharmaceutical company. The company focuses on the development of therapeutic, medical device, and diagnostic products based on adenosine 5'-triphosphate (ATP), and P2 receptors. Its products include ATPace, which is intended for the diagnosis and treatment of cardiac arrhythmias, including bardycardia and paroxysmal supraventricular tachycardia; ATPotent, a sperm medical device for the treatment of sperm in conjunction with in vitro fertilization and intra-uterine insemination procedures; Vagonixen, a drug for the treatment of chronic obstructive pulmonary disease and chronic cough; and Ocuprene, a drug for the treatment of glaucoma. The company also develops Aspirex, a diagnostic drug for the identification of patients with asthma; for differential diagnosis between chronic obstructive pulmonary disorder versus asthma; and for monitoring the efficacy of a given therapy in the management of patients with these diseases. It has strategic alliances and collaborative arrangements with Medtronic, Inc. and Cato Research, Ltd. The company was founded in 1996 and is headquartered in La Jolla, California. With 3.75 million shares outstanding and 4,500 shares declared short as of September 2008, there is no longer a failure to deliver in shares of DSKA. According to quarterly data provided by the SEC, there were still 10,705 shares of DSKA that were failing-to-deliver as of June 7, 2007.
Remote Dynamics Inc. New (OTCBB: RMTD | Quote | Chart | News | PowerRating) engages in the marketing, sale, and support of automatic vehicle location (AVL) and mobile resource management solutions targeting companies that operate private vehicle fleets in the United States. The company designs AVL solutions for metro, short-haul fleets within industry vertical markets, such as construction, field services, distribution, limousine, electrical/plumbing, waste management, and government. Its product offering includes REDIview, an Internet and service bureau-based software application that provides an array of real-time and accurate mapping, trip replay, and vehicle activity reports. The company is headquartered in Plano, Texas. Remote Dynamics, Inc. is a subsidiary of Bounce Mobile Systems, Inc. With 1.87 million shares outstanding and 3,700 shares declared short as of September 2008, there is no longer a failure to deliver in shares of RMTD.
Zynex Inc. (OTCBB: ZYXI | Quote | Chart | News | PowerRating) engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. It primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's products are useful for patients suffering with impaired mobility from stroke and spinal cord injury, as well as for those suffering from debilitating and chronic pain. Its electrotherapy products include IF 8000, an interferential and muscle stimulation device; IF 8100, a fixed program version of the IF8000; TruWave, a dual channel transcutaneous electrical nerve stimulation (TENS) device; E-Wave, a dual channel neuromuscular electrical stimulation device (NMES); and NM 900, an EMG triggered electrical stimulation device. In addition, the company distributes Elpha 3000, a dual channel NMES device; Conti4000, an electrical stimulation device for incontinence treatment; ValuTENS and Elpha 1000 Dual Channel TENS Devices; DCHT, a cervical traction device; LHT, a lumbar traction device; and electrodes that are re-usable for delivery of electrical current to the body. Zynex markets its products through commissioned, independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company, formerly known as Zynex Medical Holdings, Inc., was founded in 1998 and is headquartered in Littleton, Colorado. With 29.28 million shares outstanding and 427,900 shares declared short as of September 2008, there is no longer a failure to deliver in shares of ZYXI.
West Hawk Development Corp. (OTC: WHDCF | Quote | Chart | News | PowerRating) engages in the natural gas production, and exploration and development of coal resource properties for coal gasification and coal-to-liquids projects primarily in Canada. It primarily focuses on the Groundhog coal project located in British Columbia; the metallurgical coal project situated in Oklahoma/Arkansas basin; and the Figure 4 natural gas project in Piceance Basin, Colorado. The company was incorporated in 1984 and is headquartered in Denver, Colorado. With 68.4 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of WHDCF. According to quarterly data provided by the SEC, there were still 584,572 shares of WHDCF that were failing-to-deliver as of May 19, 2008.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,150,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
